Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'purotoxin 1'

Search results for: 'purotoxin 1'

Items 351-360 of 894

Page
per page
  1. CZC24832
    A3340 CZC24832
    Summary: Selective PI3K-γ inhibitor
      insoluble in H2O; insoluble in EtOH; ≥6.07 mg/mL
  2. T0070907
    A4301 T0070907
    Summary: Human PPARγ antagonist,potent and selective
      ≥27.8 mg/mL
  3. Topotecan
    B4982 Topotecan
     1 Citation
    Summary: Topoisomerase 1 inhibitor
      ≥21.1 mg/mL
  4. Topotecan HCl
    B2296 Topotecan HCl
    Summary: Topoisomerase 1 inhibitor
      ≥22.9 mg/mL
  5. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    Target: Topoisomerases
    Summary: Topoisomerase 1 inhibitor
      ≥23.1 mg/mL
  6. Recombinant Human IL-16, 121 a.a.
    P1128 Recombinant Human IL-16, 121 a.a.
    Summary: Interleukin-16 isoform 1
  7. Olaparib (AZD2281, Ku-0059436)
    A4154 Olaparib (AZD2281, Ku-0059436)
     12 Citation
    Summary: Potent PARP1/PARP2 inhibitor
      ≥21.72 mg/mL
  8. A-966492
    A4160 A-966492
    Target: PARP
    Summary: PARP-1/-2 inhibitor, highly potent
      ≥32.4 mg/mL
  9. Linagliptin (BI-1356)
    A4034 Linagliptin (BI-1356)
    Summary: DDP-4 inhibitor,highly potent and competitive
      insoluble in H2O; insoluble in EtOH; ≥17.85 mg/mL
  10. BMS-911543
    A4152 BMS-911543
    Target: JAK
    Summary: JAK2 inhibitor,selective small molecule
      ≥43.3 mg/mL

Items 351-360 of 894

Page
per page
Shop By
Shopping Options
Category
  1. DNA/RNA Kit1 item
  2. Biotinylation reagents and kits1 item
  3. Signaling Pathways175item
  4. Protein12item
  5. Kits10item
  6. Screening Library20item
  7. HyperScribe™ All in One mRNA Synthesis Kit3item
  8. Molecular Biology14item
  9. Probes & Dyes1 item
  10. Cell Biology82item
  11. Peptides & Proteins50item
  12. Protein & Immunology6item
  13. Cell culture1 item
  14. Chromatography1 item
  15. Antibody229item
  16. mRNA/In Vitro Transcription85item
  17. Biochemical Reagent210item
Specificity
  1. Selective37item
Reversibility
  1. Reversible2item
Target
  1. Cyclin-Dependent Kinases3item
  2. Proteasome1 item
  3. Bcl-21 item
  4. Aurora Kinases2item
  5. mTOR2item
  6. FLT33item
  7. GSK-31 item
  8. PLK1 item
  9. VEGFR5item
  10. PDGFR3item
  11. c-Kit2item
  12. IRAK2item
  13. Bcr-Abl2item
  14. MEK2item
  15. FGFR3item
  16. Insulin-like growth factor receptors(IGFRs)1 item
  17. CGRP receptors1 item
  18. Smoothened1 item
  19. Src4item
  20. Trk Receptors1 item
  21. EGFR2item
  22. JAK3item
  23. Stearoyl-CoA 9-desaturase (SCD-1)1 item
  24. Syk1 item
  25. Angiotensin AT2 Receptors1 item
  26. Topoisomerases1 item
  27. c-MET1 item
  28. PKC1 item
  29. Insulin and Insulin-like Receptors1 item
  30. PARP2item
  31. ALK1 item
  32. PKA1 item
  33. phosphatases1 item
  34. COX1 item
  35. Aldehyde Dehydrogenases1 item
  36. Guanylyl Cyclases1 item
  37. Histone Demethylases1 item
  38. ZAP-701 item
  39. Angiotensin AT1 Receptors1 item
  40. KDR1 item
  41. Fyn kinase1 item
  42. Protein polybromo-11 item
  43. SMARCA41 item
  44. SMARCA21 item
  45. Stem Cell Differentiation1 item
  46. PP2A/Nkd interaction1 item
  47. Lck1 item
  48. Flk11 item
  49. Bcl-w1 item
  50. PPK1 item
  51. c-Syk1 item
  52. CDK1/CyclinB1 item
  53. IDO1 item
Reported Experiments
  1. Animal Experiments42item
  2. Cell Experiments41item
Related Disease
  1. Acute Myeloid Leukemia1 item
  2. Adrenocortical Carcinoma1 item
  3. Bladder Cancer2item
  4. Breast Cancer2item
  5. Cancer25item
  6. Clear Cell Renal Cell Carcinoma1 item
  7. Colon Cancer1 item
  8. Colon Carcinoma2item
  9. Colorectal Cancer5item
  10. Diabetes1 item
  11. Glioblastoma2item
  12. Hepatocellular Carcinoma1 item
  13. Leukemia1 item
  14. Lung Cancer1 item
  15. Lung Carcinoma1 item
  16. Lymphoma1 item
  17. Multiple Myeloma1 item
  18. Myeloma1 item
  19. Non-small Cell Lung Cancer3item
  20. Ovarian Cancer1 item
  21. Pancreatic Cancer3item
  22. Renal Cancer1 item
  23. Rheumatoid Arthritis1 item
  24. Type 2 Diabetes1 item